Aurora Cannabis Inc. - Common Shares (ACB)
4.6400
-0.0400 (-0.85%)
NASDAQ · Last Trade: Apr 29th, 7:38 PM EDT
Detailed Quote
Previous Close | 4.680 |
---|---|
Open | 4.710 |
Bid | 4.610 |
Ask | 4.770 |
Day's Range | 4.570 - 4.906 |
52 Week Range | 3.422 - 9.350 |
Volume | 1,494,296 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 998,147 |
Chart
About Aurora Cannabis Inc. - Common Shares (ACB)
Aurora Cannabis Inc. is a leading company in the cannabis industry, primarily focused on the production and distribution of medical and recreational cannabis products. With a commitment to sustainability and innovation, the company cultivates a diverse range of cannabis strains and products, including dried flower, oils, and edibles, aimed at meeting the demands of consumers and patients alike. Aurora operates through a network of facilities and has established a strong presence in multiple international markets, working to advance the understanding and benefits of cannabis through research and development. The company is dedicated to promoting responsible usage and prioritizes quality and compliance within its operations. Read More
News & Press Releases
420 with CNW — New York’s Social Equity Program Grapples with Predatory Investors
In 2022, a couple, Kim Stetz and her partner Marq Hayes submitted an application for a Conditional Adult-Use Recreational Dispensary (CAURD) license . Their goal was to open an adult-use marijuana store called Brown Budda in New York.
Via Investor Brand Network · April 29, 2025
420 with CNW — New York’s Social Equity Program Grapples with Predatory Investors
In 2022, a couple, Kim Stetz and her partner Marq Hayes submitted an application for a Conditional Adult-Use Recreational Dispensary (CAURD) license . Their goal was to open an adult-use marijuana store called Brown Budda in New York.
Via CannabisNewsWire · April 29, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 9, 2025
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Via Benzinga · March 28, 2025
Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon."
Via Benzinga · March 27, 2025
California’s legal marijuana production rose by 11.8% in 2024, reaching 1.4 million pounds, according to a newly released report by the state’s Department of Cannabis Control (DCC).
Via CannabisNewsWire · March 27, 2025
California’s legal marijuana production rose by 11.8% in 2024, reaching 1.4 million pounds, according to a newly released report by the state’s Department of Cannabis Control (DCC).
Via Investor Brand Network · March 27, 2025
Aurora Cannabis announces breakthrough discovery of powdery mildew-resistant cultivars, providing a critical solution to a pressing challenge in the cannabis industry. This research could lead to cleaner, safer products for consumers.
Via Benzinga · March 21, 2025
Aurora shares are trading higher on Thursday after the company announced it discovered a novel source of genetic resistance against powdery mildew.
Via Benzinga · March 20, 2025
Mariners Remain Stuck in a Cannabis Testing Gray Area
Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the U.S. for several decades now but maritime employers say they are limiting the pool of eligible employees they can tap into.
Via CannabisNewsWire · March 14, 2025
Mariners Remain Stuck in a Cannabis Testing Gray Area
Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the U.S. for several decades now but maritime employers say they are limiting the pool of eligible employees they can tap into.
Via Investor Brand Network · March 14, 2025
420 with CNW — Trump’s Cuts to Funding Put Marijuana Research at Risk
The federal government’s decision to reduce funding for research is jeopardizing 565 cannabis-related studies. In addition, a freeze on new grants from the National Institutes of Health (NIH) is slowing down future studies at a critical time, raising concerns about cannabis policy changes and potential consequences for the industry.
Via CannabisNewsWire · March 6, 2025
420 with CNW — Trump’s Cuts to Funding Put Marijuana Research at Risk
The federal government’s decision to reduce funding for research is jeopardizing 565 cannabis-related studies. In addition, a freeze on new grants from the National Institutes of Health (NIH) is slowing down future studies at a critical time, raising concerns about cannabis policy changes and potential consequences for the industry.
Via Investor Brand Network · March 6, 2025